LC-MS Tools Used to Characterize Drug Degradation Products
Researchers in the Department of Pharmaceutical Analysis at the National Institute of Pharmaceutical Education and Research (Punjab, India) have published new research using liquid chromatography-mass spectrometry (LC-MS) tools to characterize degradation products of the nonsteroidal anti-inflammatory drugs piroxicam and meloxicam.
Researchers in the Department of Pharmaceutical Analysis at the National Institute of Pharmaceutical Education and Research (Punjab, India) have published new research using liquid chromatography–mass spectrometry (LC–MS) tools to characterize degradation products of the nonsteroidal anti-inflammatory drugs piroxicam and meloxicam.
The degradation behavior of the two drugs was studied by subjecting the drugs individually to hydrolytic (acidic, basic, and neutral), oxidative, photolytic, and thermal stress. Both drugs showed significant degradation in hydrolytic, oxidative, and photoneutral conditions, although they were stable under dry heat and on exposure to light in the solid state. In total, five and four degradation products were formed from piroxicam and meloxicam, respectively. To characterize the degradation products, mass fragmentation pathways of both drugs were established using mass spectrometry–time of flight (MS-TOF), multiple-stage mass spectrometry (MSn), and hydrogen–deuterium (H/D) exchange mass studies, followed by LC–MS-TOF and on-line H/D exchange experiments on the degradation products.
The collected data helped to identify the degradation products of both the drugs. The researchers were able to establish degradation pathways and proposed mechanisms for the formation of the degradation products.
The study was published on-line on 18 October as an advance article in the journal Analytical Methods.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
